SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-003181
Filing Date
2023-03-20
Accepted
2023-03-20 16:36:29
Documents
16
Period of Report
2023-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 42674
2 PRESS RELEASE drma_ex991.htm EX-99.1 11062
3 PRESS RELEASE drma_ex992.htm EX-99.2 9245
  Complete submission text file 0001654954-23-003181.txt   214759

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA drma-20230316.xsd EX-101.SCH 6017
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20230316_lab.xml EX-101.LAB 16504
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20230316_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20230316_pre.xml EX-101.PRE 12073
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20230316_def.xml EX-101.DEF 3984
10 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 4977
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 23746752
SIC: 2834 Pharmaceutical Preparations